[go: up one dir, main page]

ES2103847T3 - Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol. - Google Patents

Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol.

Info

Publication number
ES2103847T3
ES2103847T3 ES92105292T ES92105292T ES2103847T3 ES 2103847 T3 ES2103847 T3 ES 2103847T3 ES 92105292 T ES92105292 T ES 92105292T ES 92105292 T ES92105292 T ES 92105292T ES 2103847 T3 ES2103847 T3 ES 2103847T3
Authority
ES
Spain
Prior art keywords
thyamides
amides
inhibitors
azadecalinas
cholesterol biosynthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92105292T
Other languages
English (en)
Inventor
Marion W Wannamaker
Sickle William A Van
William R Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2103847T3 publication Critical patent/ES2103847T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)

Abstract

NUEVAS AMIDAS Y TIAMIDAS AZADECALINAS COMO INHIBIDORES DEL BIOSINTESIS DE COLESTEROL. COMPUESTOS DE LA FORMULA DONDE E ES O O S G ES A CON CONFIGURACION DE CADENA RECTA O RAMIFICADA; Y ES OXIGENO, AZUFRE, SULFINIL O SULFONIL; B ES UN ALCALI C1 CON CONFIGURACION DE CADENA RECTA O RAMIFICADA; D ES UN ALCALI C1 CTA O RAMIFICADA, CF3 OTALIDAD DEL SUERO DE COLESTEROL EN PACIENTES QUE LO NECESITEN.
ES92105292T 1991-03-27 1992-03-27 Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol. Expired - Lifetime ES2103847T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/676,149 US5084461A (en) 1991-03-27 1991-03-27 Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis

Publications (1)

Publication Number Publication Date
ES2103847T3 true ES2103847T3 (es) 1997-10-01

Family

ID=24713429

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92105292T Expired - Lifetime ES2103847T3 (es) 1991-03-27 1992-03-27 Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol.

Country Status (18)

Country Link
US (2) US5084461A (es)
EP (1) EP0506072B1 (es)
JP (1) JP3172975B2 (es)
KR (1) KR100224046B1 (es)
AT (1) ATE153021T1 (es)
AU (1) AU641089B2 (es)
CA (1) CA2063938C (es)
DE (1) DE69219660T2 (es)
DK (1) DK0506072T3 (es)
ES (1) ES2103847T3 (es)
FI (1) FI102373B (es)
GR (1) GR3024367T3 (es)
HU (1) HUT66656A (es)
IE (1) IE920969A1 (es)
IL (1) IL101373A (es)
NO (1) NO178301C (es)
NZ (1) NZ242108A (es)
ZA (1) ZA922107B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348964A (en) * 1990-07-25 1994-09-20 Merrell Dow Pharmaceuticals Inc. Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
US5350758A (en) * 1992-07-08 1994-09-27 Merrell Dow Pharmaceuticals Inc. Piperidyl sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
US5466687A (en) * 1992-10-22 1995-11-14 Dr. Karl Thomae Gmbh Arylidene-1-azacycloalkanes and arylalkyl-1-azacyclo-alkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
DE4303840A1 (de) * 1992-10-22 1994-08-11 Thomae Gmbh Dr K Aryliden-1-azacycloalkane und Arylalkyl-1-azacycloalkane, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
FR2697252B1 (fr) * 1992-10-28 1994-12-09 Fournier Ind & Sante Dérivés de 1,2,3,5,6,7,8,8a-octahydro-5,5,8a-triméthyl-(8abeta)-6-isoquinolineamine, leur procédé de préparation et leur utilisation en thérapeutique.
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008045564A2 (en) * 2006-10-12 2008-04-17 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CA2708364A1 (en) 2007-12-11 2009-06-18 Efrat Ben-Zeev Carboxamide compounds and their use as chemokine receptor agonists
WO2011145022A1 (en) 2010-05-21 2011-11-24 Pfizer Inc. 2-phenyl benzoylamides
EP2680874A2 (en) 2011-03-04 2014-01-08 Pfizer Inc Edn3-like peptides and uses thereof
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
AU2020209215B2 (en) 2019-01-18 2023-02-02 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof
CN111334460A (zh) * 2020-03-30 2020-06-26 江苏师范大学 一种抑制黄曲霉温度耐受性的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
US5039801A (en) * 1985-12-20 1991-08-13 The United States Of America As Represented By The Department Of Health & Human Services Thermal fragmentation of methylbenzylurea disastereomers or secondary amines and preparation of optically active secondary amines
US4792555A (en) * 1987-03-20 1988-12-20 American Home Products Corporation Phospholipase A2 inhibitors
DK168069B1 (da) * 1987-11-11 1994-01-31 Hoffmann La Roche Isoquinolinderivater og en fremgangsmaade til fremstilling af octahydroisoquinoliner ud fra derivaterne
NZ230121A (en) * 1988-08-29 1993-08-26 Squibb & Sons Inc Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis
US5124337A (en) * 1991-05-20 1992-06-23 Schering Corporation N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase

Also Published As

Publication number Publication date
FI102373B1 (fi) 1998-11-30
DE69219660D1 (de) 1997-06-19
KR100224046B1 (ko) 1999-10-15
EP0506072A1 (en) 1992-09-30
IE920969A1 (en) 1992-10-07
US5278171A (en) 1994-01-11
AU641089B2 (en) 1993-09-09
NO921187D0 (no) 1992-03-26
NZ242108A (en) 1993-09-27
GR3024367T3 (en) 1997-11-28
NO178301C (no) 1996-02-28
ATE153021T1 (de) 1997-05-15
HU9200944D0 (en) 1992-05-28
NO921187L (no) 1992-09-28
JP3172975B2 (ja) 2001-06-04
JPH05140112A (ja) 1993-06-08
AU1309092A (en) 1992-10-01
IL101373A0 (en) 1992-11-15
CA2063938C (en) 2002-08-13
FI921327A0 (fi) 1992-03-26
FI921327L (fi) 1992-09-28
CA2063938A1 (en) 1992-09-28
FI102373B (fi) 1998-11-30
KR920018028A (ko) 1992-10-21
DK0506072T3 (es) 1997-06-09
NO178301B (no) 1995-11-20
IL101373A (en) 1996-10-16
EP0506072B1 (en) 1997-05-14
US5084461A (en) 1992-01-28
HUT66656A (en) 1994-12-28
ZA922107B (en) 1992-11-25
DE69219660T2 (de) 1997-09-11

Similar Documents

Publication Publication Date Title
ES2103847T3 (es) Azadecalinas amidas y tiamidas como inhibidores de la biosintesis del colesterol.
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
BR9611615A (pt) Aril ou heteroarilamidas substituídas tendo uma atividade biológica semelhante à retinóide
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
DE3852909D1 (de) Lineare Kette von Parallelprozessoren und Benutzungsverfahren davon.
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
ATE32730T1 (de) Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen.
DE69520140D1 (de) Für den Chemilumineszenz-Nachweis verwendbare Aryl-n-Alkylacridanthiocarboxylat-Derivate
MX9204495A (es) Reduccion catalitica de nox usando metano en la presencia de oxigeno.
ES2055972T3 (es) Composicion farmaceutica o cosmetica que contiene en asociacion un retinoide y un esterol.
ATE308999T1 (de) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
IT1285770B1 (it) Composti corticoidei
MY127047A (en) Disposable diaper
ES2051695T3 (es) Tratamiento de la trombosis que contiene un fibrinolitico y un analogo de carbaciclina.
ATE258797T1 (de) Verwendung von amifostin
TR200001288T2 (tr) Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler.
DE69200861D1 (de) Konzentration von tert.-Butyl-Hydroperoxid.
DK0599114T3 (da) Vitamin D3-analoge
FI862132A0 (fi) Cytostatiskt verksamma titanocenkomplex.
KR880009661A (ko) 궤양성 대장염치료를 위한 사람의 혈액응고인자 xiii의 용도
ES2120506T3 (es) Nuevas amidas, sulfonamidas y sulfonamidas de piperidilo utilizadas como inhibidores de la biosintesis del colesterol.
ES2135535T3 (es) Derivados tiazolotriazol y tiazolodiazol con actividad fungicida.
FI873060A7 (fi) Modifioitu kudosplasmiiniaktivaattori.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506072

Country of ref document: ES